Investigators explored the impact of epigenetic modifiers and differentiation agents on leukemia cell lines of B cell origin, as well as normal B cells.
[Frontiers in Immunology]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Cell Therapy News Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for...
